Vitreoretinal Consultants of NY

Through our participation in cutting-edge clinical trials, we are committed to the fight against blindness. We have been involved in some of the most significant research endeavors, including the first clinical trials for medications such as Lucentis, Avastin, and Eylea, which are now considered standard treatment modalities for a variety of retinal and macular conditions. Our research is conducted using the most advanced diagnostic technologies and is focused on developing new or significantly improved treatments. Most importantly, we are dedicated to pursuing research that is beneficial and safe for our patients. Our research focuses on the full range of retinal and macular diseases, including age-related macular degeneration, diabetic retinopathy, macular edema, and more. For more information or to inquire about research at VRC, please contact Kristen D'Amore at [email protected] or call 516-466-0390 ext. 222.